A Phase III Randomized, Double-Blind, Neoadjuvant Study of Hormonal Therapy plus Palbociclib versus Hormonal Therapy plus Placebo in Women with Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer

Project: Research

Project Details

StatusActive
Effective start/end date14/01/2013/01/25

Keywords

  • clinical trial
  • phase 3 study
  • treatment efficacy
  • breast cancer